Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Cyclopropanation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis of Solanoeclepin A intermediate SA-01 via asymmetric cyclopropanation. High yield, scalable route for potato cyst nematode control agents.
Patent CN1852887A details a novel asymmetric copper complex for high-selectivity cyclopropanation, offering cost reduction in pyrethroid manufacturing and reliable supply chain solutions.
Patent CN110467527A reveals ruthenium-catalyzed route for high-purity agrochemical intermediate with significant cost and supply chain advantages.
Novel preparation method for Compound I (CAS 565456-77-1) via efficient cyclopropanation. Reduces toxicity and steps for API manufacturing supply chains.
Patent CN104193645A reveals efficient asymmetric synthesis. Delivers >99.5% ee. Ideal for Cilastatin production. Cost-effective supply chain solution for global buyers.
Patent CN1384105A details a robust asymmetric copper complex for cyclopropanation, offering significant cost reduction in agrochemical intermediate manufacturing and enhanced supply chain reliability.
Patent CN113896662A details a high-yield rhodium-catalyzed synthesis for chiral aminocyclopropane intermediates, offering significant cost and supply chain advantages.
Novel side-arm ferrocene ligands enable efficient asymmetric cyclopropanation for pyrethroid production with high yield and selectivity.
Advanced asymmetric copper complex technology for high-purity cyclopropane carboxylates. Enables cost reduction in pharmaceutical intermediates manufacturing and agrochemical production.
Patent CN1798609A reveals a novel copper catalyst system enabling high-yield, low-temperature synthesis of optically active cyclopropane compounds for pyrethroid production.
Efficient rhodium-catalyzed asymmetric cyclopropanation for antiviral drug intermediates. High enantioselectivity and scalable process for pharmaceutical manufacturing.
Patent CN110128341A reveals high-yield chiral cyclopropane synthesis. Achieve cost reduction in chiral ligand manufacturing with scalable supply.
Advanced synthesis of Simeprevir intermediate via patent CN105348144B offers high purity and safer manufacturing for global pharmaceutical supply chains.
Patent CN105348144B details a high-purity synthetic route for Simeprevir intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN115286559B reveals a three-step route for Paxlovid key intermediate offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced patent CN104628622A offers high-yield Saxagliptin intermediate synthesis. Ensures supply chain stability and cost efficiency for global pharma.
Patent CN103450071A details a high-yield asymmetric synthesis for HCV drug intermediates, offering cost-effective scalable manufacturing solutions.
Patent CN116135835B reveals a novel copper-catalyzed asymmetric cyclopropanation method. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability for global buyers.
Novel ruthenium-catalyzed asymmetric cyclopropanation achieves high enantioselectivity trans-D-chrysanthemic acid with simplified process flow ensuring reliable supply chain efficiency for agrochemical manufacturers.
Patent CN108314655A enables high-purity chiral nucleoside synthesis with 99% ee, reducing API manufacturing costs and ensuring reliable supply chain for pharmaceutical intermediates.